Use of oral moist snuff and inflammatory bowel disease.
We examined the association between oral moist snuff use and inflammatory bowel disease in a case-control study based on the population in Stockholm County.
The relative risk (RR) associated with ever use of moist snuff was 2, 1 (95% Cl:1.0-4.6) for Crohn's disease, and 2.2 (95% Cl:1.1-4.4) for ulcerative colitis.
Cigarette smoking indicated a synergistic relation with moist snuff: the RR estimate of Crohn's disease was 3.7 (95% Cl:1.1-13.11 and of ulcerative colitis 3.3 (95% Cl:1.0-10.9) for snuff dippers who were also current cigarette smokers, but only 0.9 and 1.1 respectively for snuff dippers who had never smoked.
Mots-clés Pascal : Tabac sans fumée, Voie orale, Toxicité, Homme, Epidémiologie, Rectocolite ulcérohémorragique, Entérite Crohn, Suède, Europe, Appareil digestif pathologie, Intestin pathologie, Maladie inflammatoire, Tabac à priser
Mots-clés Pascal anglais : Smokeless tobacco, Oral administration, Toxicity, Human, Epidemiology, Ulcerative colitis, Crohn disease, Sweden, Europe, Digestive diseases, Intestinal disease, Inflammatory disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0148670
Code Inist : 002B03E. Création : 199406.